Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational Studies
Background: Arachidonic acid (ARA) is a precursor of various lipid mediators. ARA metabolites such as thromboxane A2 cause platelet aggregation and vasoconstriction, thus may lead to atherosclerotic disease. It is unclear whether dietary ARA influences the ARA-derived lipid mediator balance and the...
Main Authors: | Mai Sakai, Saki Kakutani, Hisanori Tokuda, Toshihide Suzuki, Masaru Kominami, Kahori Egawa, Kayo Saito, Tomohiro Rogi, Hiroshi Kawashima, Hiroshi Shibata, Satoshi Sasaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-11-01
|
Series: | Cerebrovascular Diseases Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/367588 |
Similar Items
-
Trends in Nested Case-Control Studies as Compared to Case-Control and Cohort Designs, 1996-2005
by: R Chaman, et al.
Published: (2006-03-01) -
Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
by: Takuro Okamura, et al.
Published: (2021-02-01) -
The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study
by: Masaharu Nagata
Published: (2017-12-01) -
Evaluation of Tuberculosis Recurrence and Its Determinants in the Southeast of Iran: A Nested Case-Control Study Based on Data From 2012 to 2018
by: B Moatamedizadeh, et al.
Published: (2020-06-01) -
Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study
by: Kakutani Saki, et al.
Published: (2011-12-01)